Search for other papers by Anna-Pauliina Iivonen in
Google Scholar
PubMed
Search for other papers by Johanna Känsäkoski in
Google Scholar
PubMed
Search for other papers by Kirsi Vaaralahti in
Google Scholar
PubMed
New Children’s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland
Search for other papers by Taneli Raivio in
Google Scholar
PubMed
results from mutations affecting GnRH signaling, whereas in the case of KS, development of the olfactory system along with the development and/or migration of the GnRH neurons are disrupted ( 1 , 3 ). These diseases have great phenotypic and genetic
Search for other papers by Catarina I Gonçalves in
Google Scholar
PubMed
Search for other papers by José M Aragüés in
Google Scholar
PubMed
Search for other papers by Margarida Bastos in
Google Scholar
PubMed
Search for other papers by Luísa Barros in
Google Scholar
PubMed
Search for other papers by Nuno Vicente in
Google Scholar
PubMed
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Search for other papers by Manuel C Lemos in
Google Scholar
PubMed
gland, and its activation induces LH and FSH secretion ( 5 ). GNRHR mutations explain about 3.5–16% of sporadic cases and up to 40% of familial cases of nCHH ( 6 ). Inheritance is autosomal recessive and patients usually have homozygous or compound
Search for other papers by Mahmoud Al-Masri in
Google Scholar
PubMed
Search for other papers by Tawfiq Al-Shobaki in
Google Scholar
PubMed
Search for other papers by Hani Al-Najjar in
Google Scholar
PubMed
Search for other papers by Rafal Iskanderian in
Google Scholar
PubMed
Search for other papers by Enas Younis in
Google Scholar
PubMed
Search for other papers by Niveen Abdallah in
Google Scholar
PubMed
Search for other papers by Abdelghani Tbakhi in
Google Scholar
PubMed
Search for other papers by Hussam Haddad in
Google Scholar
PubMed
Search for other papers by Mohammad Al-Masri in
Google Scholar
PubMed
Search for other papers by Zeinab Obeid in
Google Scholar
PubMed
Search for other papers by Awad Jarrar in
Google Scholar
PubMed
stage of the disease. However, the role of associated gene mutations on these parameters is unclear. The majority of PTC are clinically inert with simple genetic makeup harbouring a few copy-number modifications. In terms of whole-exome sequencing, PTC
Search for other papers by Huy Gia Vuong in
Google Scholar
PubMed
Search for other papers by Uyen N P Duong in
Google Scholar
PubMed
Search for other papers by Ahmed M A Altibi in
Google Scholar
PubMed
Search for other papers by Hanh T T Ngo in
Google Scholar
PubMed
Search for other papers by Thong Quang Pham in
Google Scholar
PubMed
Search for other papers by Hung Minh Tran in
Google Scholar
PubMed
Search for other papers by Greta Gandolfi in
Google Scholar
PubMed
Search for other papers by Lewis Hassell in
Google Scholar
PubMed
pathogenesis in PTC. Several genetic alterations have been described in PTC ( 4 ). Among them, BRAF mutation, especially BRAF V600E , is the most common mutation in PTC; however, its prognostic role in PTC is still debated ( 5 , 6 , 7 ). Another recently
Search for other papers by Nathalia Liberatoscioli Menezes Andrade in
Google Scholar
PubMed
Search for other papers by Mariana Ferreira de Assis Funari in
Google Scholar
PubMed
Search for other papers by Alexsandra Christianne Malaquias in
Google Scholar
PubMed
Search for other papers by Paulo Ferrez Collett-Solberg in
Google Scholar
PubMed
Search for other papers by Nathalia L R A Gomes in
Google Scholar
PubMed
Departamento de Medicina, Faculdade de Ciencias Medicas da Santa Casa de Sao Paulo, Sao Paulo, Brasil
Search for other papers by Renata Scalco in
Google Scholar
PubMed
Search for other papers by Naiara Castelo Branco Dantas in
Google Scholar
PubMed
Search for other papers by Raissa C Rezende in
Google Scholar
PubMed
Search for other papers by Angelica M F P Tiburcio in
Google Scholar
PubMed
Search for other papers by Micheline A R Souza in
Google Scholar
PubMed
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular (LIM42), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, Brasil
Search for other papers by Bruna L Freire in
Google Scholar
PubMed
Search for other papers by Ana C V Krepischi in
Google Scholar
PubMed
Search for other papers by Carlos Alberto Longui in
Google Scholar
PubMed
Search for other papers by Antonio Marcondes Lerario in
Google Scholar
PubMed
Search for other papers by Ivo J P Arnhold in
Google Scholar
PubMed
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular (LIM42), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, Brasil
Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular (LIM42), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, Brasil
Search for other papers by Gabriela Andrade Vasques in
Google Scholar
PubMed
, one in CBL gene, one in PTPN11 , one in BRAF ). In addition, we observed an allelic imbalance suggesting mosaicism in one NF1de novo mutation ( Tables 2 and 3 ). Three CNVs were heterozygous deletions related to the SHOX gene, and one is a
Department of General Surgery, Tangdu Hospital, Air Force Medical University, Xi’an, Shaanxi, People’s Republic of China
Search for other papers by Lijuan Yuan in
Google Scholar
PubMed
Search for other papers by Xihui Chen in
Google Scholar
PubMed
Search for other papers by Ziyu Liu in
Google Scholar
PubMed
Search for other papers by Dan Wu in
Google Scholar
PubMed
Search for other papers by Jianguo Lu in
Google Scholar
PubMed
Search for other papers by Guoqiang Bao in
Google Scholar
PubMed
Search for other papers by Sijia Zhang in
Google Scholar
PubMed
Search for other papers by Lifeng Wang in
Google Scholar
PubMed
Search for other papers by Yuanming Wu in
Google Scholar
PubMed
affected ( 2 , 6 , 7 ). The first molecular genetic mutation related to PHO was identified in HPGD (MIM 601688) gene, which involved in the prostaglandin E2 metabolic pathway ( 8 ). HPGD encodes 15-hydroxyprostaglandin dehydrogenase (15-PGDH, EC 1
Search for other papers by Sara Ahmadi in
Google Scholar
PubMed
Search for other papers by Iñigo Landa in
Google Scholar
PubMed
mutually exclusive mutations of BRAF , RAS or through gene rearrangements involving RET and other receptor tyrosine kinases (RTK) ( 2 ). Even though all these alterations activate MAPK signaling, BRAF -mutant, RAS -mutant, and RET -rearranged
Search for other papers by Yiqiang Huang in
Google Scholar
PubMed
Search for other papers by Lin-ang Wang in
Google Scholar
PubMed
Search for other papers by Qiubo Xie in
Google Scholar
PubMed
Search for other papers by Jian Pang in
Google Scholar
PubMed
Search for other papers by Luofu Wang in
Google Scholar
PubMed
Search for other papers by Yuting Yi in
Google Scholar
PubMed
Search for other papers by Jun Zhang in
Google Scholar
PubMed
Search for other papers by Yao Zhang in
Google Scholar
PubMed
Search for other papers by Rongrong Chen in
Google Scholar
PubMed
Search for other papers by Weihua Lan in
Google Scholar
PubMed
Search for other papers by Dianzheng Zhang in
Google Scholar
PubMed
Search for other papers by Jun Jiang in
Google Scholar
PubMed
mortality due to hypersecretion of catecholamines and metanephrines, which induce hypertension and cardiovascular diseases. It is estimated that ~30% PCC/PGLs are genetically inherited disease, and this percentage may rise as new PCC/PGL-causing mutations
Department of Nephrology & Key Laboratory of Nephrology, National Health Commission and Guangdong Province, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Search for other papers by Lanping Jiang in
Google Scholar
PubMed
Renal Division, Children’s Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China
Search for other papers by Xiaoyan Peng in
Google Scholar
PubMed
Search for other papers by Bingbin Zhao in
Google Scholar
PubMed
Search for other papers by Lei Zhang in
Google Scholar
PubMed
Search for other papers by Lubin Xu in
Google Scholar
PubMed
Search for other papers by Xuemei Li in
Google Scholar
PubMed
Search for other papers by Min Nie in
Google Scholar
PubMed
Search for other papers by Limeng Chen in
Google Scholar
PubMed
Introduction Gitelman syndrome (GS, OMIM263800) is a recessively inherited salt-losing tubulopathy caused by mutations of SLC12A3 gene, which encodes the thiazide-sensitive human Na–Cl co-transporter (hNCC NM_000339.2; OMIM 600968) ( 1 , 2
Search for other papers by R Solomon-Zemler in
Google Scholar
PubMed
Raphael Recanati Genetic Institute, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
Felsenstein Medical Research Center, Petach Tikva, Israel
Pediatric Genetics, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by L Basel-Vanagaite in
Google Scholar
PubMed
Search for other papers by D Steier in
Google Scholar
PubMed
Search for other papers by S Yakar in
Google Scholar
PubMed
Search for other papers by E Mel in
Google Scholar
PubMed
Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by M Phillip in
Google Scholar
PubMed
Search for other papers by L Bazak in
Google Scholar
PubMed
Search for other papers by D Bercovich in
Google Scholar
PubMed
Shalom and VardaYoran Institute for Human Genome Research, Tel Aviv University, Tel Aviv, Israel
Search for other papers by H Werner in
Google Scholar
PubMed
Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by L de Vries in
Google Scholar
PubMed
defects), IGFALS mutations and IGF1R gene mutations or rearrangements. Most reported IGF1R mutations were diagnosed in children born small for gestational age (SGA) ( 1 ). These mutations can affect ligand binding and/or reduce cell-surface IGF1R